Previous close | 136.64 |
Open | 137.55 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 136.95 - 139.76 |
52-week range | 71.57 - 141.39 |
Volume | |
Avg. volume | 1,554 |
Market cap | 233.367M |
Beta (5Y monthly) | 1.03 |
PE ratio (TTM) | 0.16 |
EPS (TTM) | 8.46 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.